Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click on 'Find out more' to see our Cookie statement.

Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.

Scientist in protective clothing working at a high-tec equipment station in a lab

The consortium has today been awarded a £6.85M grant by Innovate UK’s Industrial Strategy Challenge Fund (ISCF) to build a commercially scalable quantum computer designed to tackle prohibitively high costs within pharmaceutical drug development.

Professor Chas Bountra, Pro-Vice Chancellor for Innovation at Oxford University, says: ‘We in academia need to do everything possible to help our industry colleagues accelerate the development of new medicines for patients. I am immensely excited about this project – it is an opportunity for us to work with so many technology leaders and potentially transform the process of drug discovery. We must make it better, faster and cheaper.’

The partnership will accelerate the use of quantum computing within pharmaceutical research to dramatically reduce the time required for drug development on a global scale. 

Professor Charlotte Deane, who leads the Oxford Protein Informatics Group in the Department of Statistics and Professor Frank Von Delft, at the Centre for Medicines Discovery at the Nuffield Department of Medicine, will be leading from Oxford University.

The project is focused on developing high-value simulation tools to support photodynamic therapies for cancer treatment. Currently, useful simulations of photosensitising drugs are not possible with classical computing power alone. This ground-breaking project will develop an application-specific quantum computer designed to simulate the most classically challenging tasks within this research. 

Matthew Hutchings, co-founder and CPO at SEEQC, says: ‘Today, drug discovery is a labour and time-intensive iterative process with immense costs. Thanks to our world-leading partners and the invaluable commercial benchmarking by our end-customers at Merck, we have the opportunity to develop a quantum computing platform that can radically improve the efficiency of drug development.’ 

The custom nature of the project requires close development to build several bespoke components and enable tight integration.  

It marks the first time a quantum computer has been integrated with a high-performance computer in the same network infrastructure. The quantum computer will require a redesigned refrigerator to support cooling at multiple levels, specifically for the cryogenic decoder.

Similar stories

Next generation of innovators recognised at inaugural Jamie Ferguson Chemistry Innovation Awards

Oxford Chemistry students with innovative, game-changing ideas have been highlighted at the inaugural Jamie Ferguson Chemistry Innovation Awards ('The Jamies'), a new annual awards scheme co-developed by the Department of Chemistry and Oxford University Innovation (OUI) in honour of the late Dr Jamie Ferguson.

Researchers develop world's first ultra-fast photonic computing processor, using polarisation

The innovative technique, developed in the Department of Materials, uses multiple polarisation channels to carry out parallel processing – enhancing computing density by several orders over conventional electronic chips.

MPLS Professor Laurence Brassart and physicist Dr Archie Bott among 84 scientists awarded UKRI Future Leaders Fellowships

The Fellowships were announced by Science Minister George Freeman this morning, to help the UK’s most promising science and research leaders to tackle major global issues and commercialise their innovations within the UK.

MPLS research teams to benefit from share of £7m UKRI award

The University has been awarded more than £7 million from UK Research and Innovation (UKRI)’s Impact Acceleration Account (IAA), which supports the ‘best, brightest and most disruptive ideas’ from UK research institutions, including funding for engineering and physical science innovation.

MPLS student Hannah Rana, who recently completed a DPhil in Engineering, selected for Schmidt Science Fellowship

Hannah is one of 29 Schmidt Science Fellows selected this year to receive support for up to two years from Schmidt Futures, working in partnership with the Rhodes Trust, to help advance interdisciplinary research and innovation around major challenges facing humanity.

Museum of Natural History to showcase Science Together community-researcher collaborations

The 'Explore Science Together' event takes place at the Oxford University Museum of Natural History on Tuesday 7 June.